We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.43B
1-Year Est. Return 24.13%
This Fund
S&P 500
This Quarter Est. Return
+13%
1 Year Est. Return
+24.13%
3 Year Est. Return
+79.76%
5 Year Est. Return
+94.69%
10 Year Est. Return
+325.94%
AUM
$931M
AUM Growth
+$148M
Cap. Flow
+$49.8M
Cap. Flow %
5.35%
Top 10 Hldgs %
15.21%
Holding
980
New
142
Increased
398
Reduced
298
Closed
54

Sector Composition

Rank Sector Weight
1 Technology 12.64%
2 Healthcare 9.49%
3 Financials 9.34%
4 Consumer Discretionary 8.54%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NCZ
851
Virtus Convertible & Income Fund II
NCZ
$289M
$78K 0.01%
3,391
-727
-18% -$15.8K
DSE
852
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
$76K 0.01%
1,513
-498
-25% -$24.2K
SRRA
853
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$75K 0.01%
1,098
EFOI icon
854
Energy Focus
EFOI
$18.3M
$74K 0.01%
+1,743
New +$61.9K
ZVRA icon
855
Zevra Therapeutics
ZVRA
$563M
$72K 0.01%
+2,704
New +$99.5K
FSK icon
856
FS KKR Capital
FSK
$2.98B
$68K 0.01%
2,825
+2
+0.1% +$50
GEVO icon
857
Gevo
GEVO
$397M
$67K 0.01%
+30,500
New +$75K
CXE
858
DELISTED
MFS High Income Municipal Trust
CXE
$66K 0.01%
12,838
QNRX
859
Quoin Pharmaceuticals
QNRX
$8.6M
$66K 0.01%
+1
New +$179K
SIOX
860
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$63K 0.01%
+5,938
New +$59.1K
GASS icon
861
StealthGas
GASS
$328M
$62K 0.01%
17,844
+300
+2% +$960
WFT
862
DELISTED
Weatherford International plc
WFT
$62K 0.01%
88,553
+13,371
+18% +$9.25K
SRAX
863
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$61K 0.01%
17,883
-600
-3% -$1.74K
CCM
864
Concord Medical Services
CCM
$18.7M
$60K 0.01%
2,143
+475
+28% +$15.1K
NSL
865
DELISTED
NUVEEN SENIOR INCM FD
NSL
$60K 0.01%
10,395
-457
-4% -$2.66K
MMT
866
Aberdeen Multi-Market Income Fund
MMT
$237M
$59K 0.01%
10,311
+40
+0.4% +$222
CYTO
867
DELISTED
Altamira Therapeutics Ltd
CYTO
$59K 0.01%
+21
New +$67.5K
OPK icon
868
Opko Health
OPK
$921M
$54K 0.01%
+20,610
New +$62.4K
IMGN
869
DELISTED
Immunogen Inc
IMGN
$53K 0.01%
+19,581
New +$84.8K
NVCN
870
DELISTED
Neovasc Inc.
NVCN
$53K 0.01%
+504
New +$75.5K
AVDL
871
DELISTED
Avadel Pharmaceuticals
AVDL
$51K 0.01%
+35,535
New +$80.4K
AUY
872
DELISTED
Yamana Gold, Inc.
AUY
$51K 0.01%
19,474
GSAT icon
873
Globalstar
GSAT
$10.2B
$49K 0.01%
+7,667
New +$65.3K
AFMD
874
DELISTED
Affimed
AFMD
$46K ﹤0.01%
1,100
HSTO
875
DELISTED
Histogen Inc. Common Stock
HSTO
$46K ﹤0.01%
+215
New +$86.7K

Similar funds

Wedbush Securities's Q1 2019 Portfolio in Review

As of Q1 2019, Wedbush Securities held 980 positions worth $931M, up 19% from $782M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Wedbush Securities deployed $49.8M of net new capital in Q1 2019, opening 142 new positions and adding to 398 existing holdings. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 20,990 shares worth $2.24M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares Floating Rate Bond ETF, an estimated $1.46M trimmed.

  • Wedbush Securities's largest Q1 2019 buy was iShares 7-10 Year Treasury Bond ETF: 20,990 shares worth $2.24M.
  • Wedbush Securities added most to iShares 20+ Year Treasury Bond ETF in Q1 2019, an estimated $1.84M increase.
  • Wedbush Securities's biggest Q1 2019 reduction was iShares Floating Rate Bond ETF, cutting an estimated $1.46M.
  • Wedbush Securities fully exited State Street SPDR Portfolio Short Term Corporate Bond ETF in Q1 2019, selling an estimated $717K.
  • Wedbush Securities's ten largest holdings make up 15% of its $931M portfolio in Q1 2019.
  • Wedbush Securities opened 142 new positions and closed 54 in Q1 2019.
  • Wedbush Securities's portfolio value rose 19% quarter-over-quarter to $931M.

Based on Wedbush Securities's 13F filing for Q1 2019, filed 17 Apr 2019.